CAS # 33069-62-4
IP / USP / EP Grade (C47H51NO14)
Paclitaxel IP / USP / EP
Paclitaxel is a complex diterpenoid taxane antineoplastic API (C47H51NO14, CAS 33069-62-4) that stabilizes microtubules to interfere with cancer cell division. Indicated in ovarian cancer, breast cancer, non-small-cell lung cancer (NSCLC), and Kaposi sarcoma.
Assay / Purity
97.0% - 102.0% (Anhydrous/Solvent-Free)
Physical Appearance
White to Off-White Crystalline Powder
Documentation
CoA / DMF / GMP
Direct Procurement Quote
Fill details to receive commercial terms and Certificate of Analysis (CoA).
Technical Specifications Summary
Chemical / Product Name
Paclitaxel IP / USP / EP
CAS Registry Number
33069-62-4
Standard Grade
IP / USP / EP Grade (C47H51NO14)
Assay / Purity
97.0% - 102.0% (Anhydrous/Solvent-Free)
Appearance
White to Off-White Crystalline Powder
Formulation & Industry Applications
Injectable Formulations
Albumin-bound Paclitaxel
Oncology Chemotherapy
Related Ingredients
Explore complementary ingredients in Oncology APIs Portfolio: